Sotera Health (NASDAQ:SHC) Trading Up 5.1% - Here's What Happened

Shares of Sotera Health (NASDAQ:SHC - Get Free Report) rose 5.1% during trading on Monday . The stock traded as high as $12.98 and last traded at $13.01. Approximately 201,821 shares changed hands during trading, a decline of 83% from the average daily volume of 1,202,354 shares. The stock had previously closed at $12.38.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on SHC. Piper Sandler reduced their price objective on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. The Goldman Sachs Group upgraded shares of Sotera Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $14.00 to $17.00 in a report on Monday, May 5th. Finally, Barclays lowered their price target on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $15.80.

Sotera Health Price Performance

The firm has a market cap of $3.73 billion, a P/E ratio of 52.52 and a beta of 1.88. The stock's 50-day moving average is $11.45 and its 200-day moving average is $12.93. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $254.52 million for the quarter, compared to the consensus estimate of $245.56 million. During the same quarter in the previous year, the firm posted $0.13 EPS. The business's revenue was up 2.6% compared to the same quarter last year. As a group, equities analysts anticipate that Sotera Health will post 0.61 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Blue Trust Inc. raised its stake in shares of Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after buying an additional 1,140 shares in the last quarter. Quarry LP acquired a new position in Sotera Health in the fourth quarter worth about $28,000. GAMMA Investing LLC lifted its stake in Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock worth $56,000 after purchasing an additional 1,121 shares during the period. Tower Research Capital LLC TRC boosted its holdings in Sotera Health by 37.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after purchasing an additional 1,640 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its stake in shares of Sotera Health by 4,881.9% in the 1st quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock valued at $70,000 after purchasing an additional 6,200 shares during the period. 91.03% of the stock is owned by institutional investors.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.